Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy
dc.contributor.author | Hunyady, Béla | |
dc.contributor.author | Abonyi, Margit | |
dc.contributor.author | Gerlei, Zsuzsa | |
dc.contributor.author | Gervain, Judit | |
dc.contributor.author | Horváth, Gábor | |
dc.contributor.author | Jancsik, Viktor | |
dc.contributor.author | Lengyel, Gabriella | |
dc.contributor.author | Makkai, Erzsébet | |
dc.contributor.author | Pár, Alajos | |
dc.contributor.author | Péter, Zoltán | |
dc.contributor.author | Pusztay, Margit | |
dc.contributor.author | Ribiczey, Pál | |
dc.contributor.author | Rókusz, László | |
dc.contributor.author | Sarrazin, Christoph | |
dc.contributor.author | Schneider, Ferenc | |
dc.contributor.author | Susser, Simone | |
dc.contributor.author | Szalay, Ferenc | |
dc.contributor.author | Tornai, István | |
dc.contributor.author | Tusnádi, Anna | |
dc.contributor.author | Ujhelyi, Eszter | |
dc.contributor.author | Werling, Klára | |
dc.contributor.author | Makara, Mihály | |
dc.date.accessioned | 2019-01-09T10:26:28Z | |
dc.date.available | 2019-01-09T10:26:28Z | |
dc.date.issued | 2018 | |
dc.date.oa | 2019-03-06 | |
dc.date.pasync | 2019-03-13T01:30:27Z | |
dc.date.updated | 2019-03-13T01:30:27Z | |
dc.description.corrector | LB | |
dc.identifier.citation | Clinical and Experimental Hepatology. -4 : 2 (2018), p. 83-90. -Clin. Exp. Hepatol. - 2392-1099 | |
dc.identifier.doi | http://dx.doi.org/10.5114/ceh.2018.75957 | |
dc.identifier.issn | 2392-1099 | |
dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM076591 | |
dc.identifier.uri | http://hdl.handle.net/2437/262902 | |
dc.identifier.url | https://www.termedia.pl/doi/10.5114/ceh.2018.75957 | |
dc.language | eng | |
dc.rights.access | open access journal | |
dc.rights.owner | Termedia Publishing | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Klinikai orvostudományok | |
dc.title | Ombitasvir/paritaprevir/ritonavir + dasabuvir + ribavirin in HCV genotype 1 infected patients who failed previous protease inhibitor therapy | |
dc.type | folyóiratcikk | |
dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_1_2018 Clin Exp Hep.pdf
- Méret:
- 113.14 KB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- kiadói változat